Released Feb 22, 2017, after the close
10-K filed Feb 22, 2017, 53 days after period end · 0001558370-17-000793
Q4 2016 · 10-K
Revenue$87.46M$87.46M +64.1% vs Q4 2015+32.3% vs Q3 2016
Net Income-$13.51M-$13.51M no prior Q4 2015 on fileN/M vs Q3 2016
EPS Diluted-$0.09-$0.09 N/M vs Q4 2015N/M vs Q3 2016
Operating Incomederived-$6,300,000N/M
Operating Cash Flowderived-$19,187,000N/M
Free Cash Flowderived-$20,385,000N/M
Margins · derived
Operating margin-7.2%+3.7 pt vs Q4 2015
Net margin-15.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $87.46M | $53.31M | $38.07M | $5.03M |
| Net Income | -$13.51M | — | — | — |
| EPS Diluted | -$0.09 | -$0.09 | -$0.27 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR